Where does Tabula Rasa Healthcare, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Tabula Rasa Healthcare, Inc. ranks #43,473 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Tabula Rasa Healthcare, Inc. hold?

Tabula Rasa Healthcare, Inc. holds 6 US utility patents granted between 2020 and 2025, spanning 6 technology areas.

What is Tabula Rasa Healthcare, Inc.'s Innovation Score?

Tabula Rasa Healthcare, Inc. has an Innovation Score of 30.8 out of 100 (36th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Tabula Rasa Healthcare, Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Tabula Rasa Healthcare, Inc..

What does claim depth mean for Tabula Rasa Healthcare, Inc.'s patents?

Tabula Rasa Healthcare, Inc.'s patents average 9.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Tabula Rasa Healthcare, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Tabula Rasa Healthcare, Inc.

Q: What technology areas does Tabula Rasa Healthcare, Inc. focus on?

Tabula Rasa Healthcare, Inc.'s top technology area is G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data) with 3 patents, ranking #1,366 of 3,149 assignees active in that subclass. Grants appear in 6 CPC subclasses total.

USPTO PatentsView assignee record - 6 granted patents across 6 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Tabula ranks #43,473 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 6 technology areas.

#43,473
of 49,997 US assignees by volume: 36th percentile
by Innovation Score (30.8/100): 9.0
avg claims per patent

USPTO PatentsView assignee plate

Corpus R43473 · US Corporation #43,473 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 6 grants
LOWER-Q #43,473/49,997
PHOTO-FINISH T-rex Investment
CPC-NARROW G16H · 6 areas
INNOV-THIN 30.8/100
CLAIMS-PAR 9.0 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2020–2025 · 6y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: T-rex Investment Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Tabula’s 30.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.7 pts (22%) Velocity 10.0 pts (32%) Breadth 8.7 pts (28%) Claim depth 5.4 pts (18%)

Qualcomm Incorporated · highest

85
Tabula Rasa Healthcare · this assignee

31
3D Lighting… · lowest

7

What this shows Tabula's Innovation Score is 30.8/100 (36th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Tabula?

Each dot is one of Tabula’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Tabula’s own 9.0 claims/patent is ABOVE the 8.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Tabula vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Tabula's grants concentrate

Tabula Rasa Healthcare, Inc. is a focused PatentsView assignee: 6 CPC subclasses with 50% of grants classified under G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data). By volume, Tabula sits between T-rex Investment Inc. and Taisei Kogyo Co., Ltd..

Tabula's three-year grant acceleration

Tabula Rasa Healthcare, Inc. shows 3 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

T-rex Investment

6
T M Designworks

6
T M C S P A

6
T2M

6
Taihao Medical

6
Taihei Machinery…

6
Tair Jiuh Enterpr…

6
Taisei Kogyo

6
Tabula Rasa Healt… ◀

6

What this shows Tabula holds 6 patents at rank #43,444, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Tabula

By rank, the assignees closest to #43,444 in granted patent volume.

Leaders in G16H (Healthcare Informatics)

Other assignees with the most granted patents in Tabula's primary technology class.

Tabula's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

31 36th percentile higher than 36% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Tabula Rasa Healthcare, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	1	16.7%
2021	1	16.7%
2022	1	16.7%
2023	1	16.7%
2024	1	16.7%
2025partial year	1	16.7%

Which technologies does Tabula Rasa Healthcare, Inc. patent most?

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 3

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 2

A61B - DIAGNOSIS; SURGERY; Identification 2

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 2

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 2

G06Q - Information AND Communication Technology [ICT] Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory PURPOSES; Systems OR Methods Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory Purposes, NOT Otherwise Provided FOR 1

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Tabula Rasa Healthcare, Inc.'s patent record in context - here's where to go next.

Tabula Rasa Healthcare, Inc.'s lead technology class is G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data), 50% of its portfolio - see every assignee active in that class. Explore G16H
Ranked #43,473 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Tabula Rasa Healthcare, Inc. against T-rex Investment Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 30.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.